+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effect of a 28-d treatment with L-796568, a novel b3-adrenergic receptor agonist, on energy expenditure and body composition in obese men



Effect of a 28-d treatment with L-796568, a novel b3-adrenergic receptor agonist, on energy expenditure and body composition in obese men



The American Journal of Clinical Nutrition 76(4): 0-8




(PDF emailed within 1 workday: $29.90)

Accession: 017870373

Download citation: RISBibTeXText


Related references

Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. American Journal of Clinical Nutrition 76(4): 780-788, 2002

Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. Clinical Pharmacology and Therapeutics 71(4): 272-279, 2002

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. International Journal of Obesity and Related Metabolic Disorders 24(12): 1567-1572, 2000

Effect of diet and PPARgamma2 and beta2-adrenergic receptor genes on energy metabolism and body composition in obese women. Nutricion Hospitalaria 21(3): 317-331, 2006

Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite 49(3): 635-643, 2007

The effect of sibutramine on energy expenditure and body composition in obese adolescents. Journal of Clinical Endocrinology and Metabolism 92(4): 1409-1414, 2007

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism: Clinical and Experimental 41(7): 686-688, 1992

A 1 year weight cycle has no effect on body composition and energy expenditure in obese females. International Journal of Obesity 18(SUPPL 2): 52, 1994

Resting energy expenditure and body composition in morbidly obese, obese and control subjects. Acta Diabetologica 31(1): 47-51, 1994

Energy expenditure, body composition and insulin response to glucose in male twins discordant for the Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Diabetes, Obesity & Metabolism 8(3): 322-330, 2006

No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women. Metabolism: Clinical and Experimental 51(6): 801-805, 2002

Changes in body composition and resting energy expenditure after rapid weight loss: is there an energy-metabolism adaptation in obese patients?. International Journal of Obesity and Related Metabolic Disorders 19(2): 119-125, 1995

RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. Journal of Clinical Endocrinology and Metabolism 100(4): 1639-1645, 2015

Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. Journal of Clinical Endocrinology and Metabolism 96(3): 837-845, 2011